Bempegaldesleukin
20-214-29/CA045-022
Phase 3 mab terminated
Quick answer
Bempegaldesleukin for Melanoma is a Phase 3 program (mab) at Nektar Therapeutics UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nektar Therapeutics UK Limited
- Indication
- Melanoma
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated